<DOC>
	<DOCNO>NCT02201485</DOCNO>
	<brief_summary>Budd-Chiari syndrome ( BCS ) define hepatic outflow obstruction small hepatic vein confluence inferior vena cava right atrium , often lead life-threatening complication , liver failure portal hypertension-related complication . At present , stepwise treatment strategy employ , include anticoagulation , thrombolysis , percutaneous recanalization ( i.e. , percutaneous transluminal angioplasty [ PTA ] alone combination stent placement ) , transjugular intrahepatic portosystemic shunt , liver transplantation . In West , less 20 % BCS patient underwent percutaneous recanalization ; contrast , percutaneous recanalization common treatment modality use China . Recently , 11-year retrospective case series 177 Chinese patient primary BCS show high rate re-occlusion PTA alone group PTA combine stent placement group ( 31 % versus 7.7 % , p &lt; 0.001 ) . In addition , re-occlusion regard independent predictor mortality . Accordingly , hypothesize PTA alone might worse survival PTA combine stent placement Chinese patient primary BCS .</brief_summary>
	<brief_title>Budd-Chiari Syndrome China : Balloon Angioplasty Alone Combined With Stent Placement ?</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Budd-Chiari Syndrome</mesh_term>
	<criteria>1 . Informed consent . 2 . Age 1875 year old . 3 . BuddChiari syndrome 4 . ChildPugh score &lt; 13 point . 5 . Eligible percutaneous recanalization . 1 . Pregnancy lactation . 2 . Malignancy . 3 . HIV infection . 4 . Severe cardiac lung disease . 5 . Severe renal dysfunction ( serum &gt; 265.2 umol/l ) . 6 . Uncontrolled systemic infection . 7 . Allergic contrast agent . 8 . Poor compliance . 9 . A prior history percutaneous recanalization . 10 . Ineligible percutaneous recanalization . 11 . Liver cirrhosis severe portal hypertensionrelated complication . 12 . Acute liver failure . 13 . Progressive deterioration liver function .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Budd-Chiari syndrome</keyword>
	<keyword>percutaneous recanalization</keyword>
	<keyword>treatment</keyword>
	<keyword>reocclusion</keyword>
	<keyword>patency</keyword>
</DOC>